Atossa Therapeutics Inc (ATOS): Next-Year EPS Estimate 38.32%
As of 2026-06-04, Atossa Therapeutics Inc (ATOS) has a next-year EPS growth estimate of 38.32%.
On 2026-05-13, analyst consensus for ATOS's next-year EPS growth shifted from 45.80% to 38.32% — a negative change of 7.48 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at -9.16%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 38.32%
- EPS growth this year
- -9.16%
- EPS next quarter (est)
- -$1.08
- Last price
- $4.85
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 38.32% | -9.16% | -$1.08 | $4.85 |
| 2026-06-03 | 38.32% | -9.16% | -$1.08 | $4.70 |
| 2026-06-02 | 38.32% | -9.16% | -$1.08 | $4.85 |
| 2026-06-01 | 38.32% | -9.16% | -$1.08 | $5.11 |
| 2026-05-31 | 38.32% | -9.16% | -$1.08 | $5.23 |
| 2026-05-28 | 38.32% | -9.16% | -$1.08 | $5.19 |
| 2026-05-27 | 38.32% | -9.16% | -$1.08 | $5.12 |
| 2026-05-26 | 38.32% | -9.16% | -$1.08 | $4.95 |
| 2026-05-25 | 38.32% | -9.16% | -$1.08 | $4.96 |
| 2026-05-24 | 38.32% | -9.16% | -$1.08 | $4.96 |
| 2026-05-21 | 38.32% | -9.16% | -$1.08 | $4.97 |
| 2026-05-20 | 38.32% | -9.16% | -$1.08 | $4.84 |
| 2026-05-19 | 38.32% | -9.16% | -$1.08 | $4.74 |
| 2026-05-18 | 38.32% | -9.16% | -$1.08 | $4.78 |
| 2026-05-17 | 38.32% | -9.16% | -$1.08 | $4.85 |
| 2026-05-14 | 38.32% | -9.16% | -$1.08 | $5.15 |
| 2026-05-13 | 38.32% | -9.16% | -$1.08 | $5.24 |
| 2026-05-12 | 45.80% | -10.97% | -$1.11 | $5.16 |
| 2026-05-11 | 45.80% | -10.97% | -$1.11 | $5.50 |
| 2026-05-10 | 42.59% | 6.44% | -$0.94 | $5.60 |
| 2026-05-07 | 42.10% | 5.53% | -$0.99 | $5.67 |
| 2026-05-06 | 42.10% | 5.53% | -$0.99 | $5.80 |
| 2026-05-05 | 42.10% | 5.53% | -$0.99 | $5.58 |
| 2026-05-04 | 42.10% | 5.53% | -$0.99 | $5.86 |
| 2026-05-03 | 42.10% | 5.53% | -$0.99 | $5.33 |
| 2026-04-30 | 42.10% | 5.53% | -$0.99 | $5.37 |
| 2026-04-29 | 42.10% | 5.53% | -$0.99 | $5.28 |
| 2026-04-28 | 42.10% | 5.53% | -$0.99 | $5.49 |
| 2026-04-27 | 42.10% | 5.53% | -$0.99 | $5.45 |
| 2026-04-26 | 42.10% | 5.53% | -$0.99 | $5.70 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Atossa Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Atossa Therapeutics Inc (ATOS) has a next-year EPS growth estimate of 38.32%, based on analyst consensus.
When was the latest EPS estimate revision for ATOS?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 45.80% to 38.32%.
What sector and industry does Atossa Therapeutics Inc belong to?▾
Atossa Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ATOS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Atossa Therapeutics Inc (ATOS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports